VEGFA and pituitary gland adenoma: To further verify the vital role of angiogenesis in rhEPO induced tumor growth of pituitary adenoma cell xenografts, we administered rhEPO (2000 U/kg) plus bevacizumab (10 mg/kg), a VEGF inhibitor, to nude mice bearing xenograft tumors.